Taiwan’s Zhenjuntang Biotechnology banking on medicinal mushrooms for expansion into China

Since its establishment in 2009, Zhenjuntang Biotechnology Co. Ltd. has invested more than NT$2.2 billion across the Taiwan Strait to manage 158 operation centers in 21 of China’s provinces. The Taipei-based company aims to highlight the alleged benefits of stout camphor fungus, also called “niu zhang zhi” in Chinese, a promising medicinal mushroom from Taiwan, in the fight against cancer. Read the full story in the China Post.

發佈留言

發佈留言必須填寫的電子郵件地址不會公開。 必填欄位標示為 *